Cargando…

Antibody Response to SARS-CoV-2 in the First Batch of COVID-19 Patients in China by a Self-Developed Rapid IgM-IgG Test

It has been over two years since the COVID-19 pandemic began and it is still an unprecedented global challenge. Here, we aim to characterize the antibody profile from a large batch of early COVID-19 cases in China, from January – March 2020. More than 1,000 serum samples from participants in Hubei a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Yiyi, Weng, Youhong, Wu, Yahan, Gao, Fei, Zheng, Xiaojun, Xiong, Xianqin, Lv, Hangjun, Kong, Qingming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204641/
https://www.ncbi.nlm.nih.gov/pubmed/35719335
http://dx.doi.org/10.3389/fcimb.2022.915751